FDA Approved: PENTASA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for PENTASA (mesalamine) submitted by Takeda Pharmaceuticals America, resulting in an update to the product label.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• PENTASA (MESALAMINE)

Snippet

SUPPL AP for PENTASA (MESALAMINE)